Form 4: Omada Health President Granted 264,705 RSUs

Omada Health's President, Wei-Li Shao, was granted 264,705 restricted stock units, aligning executive incentives with long-term company performance.

Summary

• Wei-Li Shao, President of Omada Health, Inc., was granted 264,705 restricted stock units (RSUs) on March 5, 2026.
• Each RSU represents the right to receive one share of Omada Health Common Stock upon vesting.
• The RSUs will vest over four years, with 1/16th vesting on each quarterly anniversary starting from March 1, 2026.
• Following this transaction, Wei-Li Shao beneficially owns 331,679 shares of Common Stock.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it strengthens executive alignment with long-term shareholder value, a standard practice for retaining key talent.

Positives

• The grant of restricted stock units aligns the President's long-term incentives with shareholder value creation.
• The vesting schedule encourages sustained performance and retention of key management.
• The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged, non-discretionary transaction.

Negatives

• The transaction date of March 5, 2026, is in the future, meaning the shares are not immediately owned or vested.
• RSUs dilute existing shareholder equity over time as they vest and convert to common stock.

Risks

• No specific risks are detailed in this Form 4 filing beyond the inherent risks of equity compensation, such as stock price fluctuation impacting the value of the compensation.

Future Outlook

The RSUs will vest over a four-year period, with 1/16th vesting quarterly from March 1, 2026, indicating a long-term incentive structure for the President.

Industry Context

StockSavvy.ai notes that equity grants, particularly RSUs with multi-year vesting schedules, are a standard practice in the technology and healthcare sectors to attract, retain, and incentivize key executives. This aligns Omada Health with common industry compensation strategies aimed at fostering long-term growth and executive alignment with shareholder interests.

Comparison to Industry Standards

• Equity compensation for executives, especially through RSUs with a four-year vesting schedule, is a common practice across the tech and healthcare industries.
• For instance, companies like Teladoc Health (TDOC) and Livongo (acquired by TDOC) have historically utilized similar long-term incentive plans for their leadership.
• The grant size of 264,705 RSUs for a President is substantial and comparable to grants seen in similar-sized growth companies, aiming to provide significant upside potential tied to company performance.

Corporate Governance

Related Party Transactions

• Grant of 264,705 Restricted Stock Units to Wei-Li Shao, President of Omada Health, Inc., as part of his compensation package.

Stakeholder Impact

• Shareholders: Potential for long-term value creation through executive alignment; minor dilution from RSU conversion over time.
• Employees: May signal confidence in the company's future and reinforce the value of equity compensation.
• Management: Increased incentive to drive long-term company performance and retention.

Next Steps

• Quarterly vesting of 1/16th of the RSUs will commence from March 1, 2026.
• Full vesting of the RSUs is expected on the fourth anniversary of the Vesting Commencement Date.

Key Dates

Recommendation

This Form 4 filing details a routine executive compensation grant and does not provide new information that would significantly alter the fundamental outlook or valuation of Omada Health. While it reinforces management's long-term alignment, it's a standard practice and not a catalyst for a strong buy or sell recommendation based solely on this filing. Investors should hold and consider broader company performance and market conditions.

Keywords

Omada Health, OMDA, SEC Form 4, Restricted Stock Units, RSUs, Executive Compensation, Wei-Li Shao, Insider Transaction, Equity Grant, Corporate Governance